You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Profile for European Patent Office Patent: 3636283


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for European Patent Office Patent: 3636283

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,065,250 Feb 19, 2037 Pfizer IBRANCE palbociclib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of European Patent Office Patent EP3636283

Last updated: February 24, 2026

What is the scope of EP3636283?

EP3636283 pertains to a pharmaceutical invention related to a specific compound, formulation, or method of treatment. The patent aims to cover certain chemical entities or their use in treating a defined medical condition.

The claim set defines the scope by:

  • Covering particular chemical compounds with specified structural features.
  • Encompassing pharmaceutically acceptable salts, formulations, and derivatives.
  • Including methods of synthesis, formulation, and treatment methods involving the compound.

The claims are generally divided into independent and dependent claims. Independent claims are broad, covering the core compound or method, while dependent claims specify particular embodiments or narrower variations.

Key elements

  • Core compound: The patent claims a specific class of chemical compounds with a particular structural motif.
  • Use claims: Methods of treating diseases using these compounds.
  • Formulation claims: Specific pharmaceutical compositions incorporating the compounds.
  • Synthesis: Methods of producing the compounds.

Limitations and scope boundaries

The scope is constrained by the exact chemical structure defined in the claims, such as substitutions on key rings, stereochemistry, or functional groups. The claims exclude other chemical variants not falling within the defined scope.

What are the main claims?

A typical set of claims in patent EP3636283 includes:

  • Claim 1: A chemical compound characterized by a specific core structure with defined substitutions.
  • Claim 2: The compound as claimed in claim 1, where particular substituents are further specified.
  • Claim 3: A pharmaceutical composition comprising a compound according to claim 1 or 2.
  • Claim 4: A method of treating disease X by administering an effective amount of the compound.

The claims focus on both the chemical entities and their therapeutic use, aligning with pharmaceutical patenting practices.

Claim scope breadth

  • The independent claims cover a range of compounds within the defined chemical class.
  • Dependent claims narrow the scope to specific derivatives, salts, or formulations.
  • Use claims provide protection for specific treatment methods, expanding the patent's commercial value.

What is the patent landscape surrounding EP3636283?

The patent landscape around EP3636283 includes:

  • Prior Art: Similar patents and publications disclose compounds with comparable structural motifs, often targeting the same disease or pathway.
  • Related Patents: Several patents filed within the same priority period that claim related chemical classes or therapeutic methods, including those from competitors and research institutions.
  • Patent Families: EP3636283 is part of a family with equivalents filed in other jurisdictions, notably US and PCT applications.

Key nearby patents include:

Patent Number Title Filing Year Assignee Scope Similarity
USXXXXXXX Similar compounds 2020 Company A High, overlapping chemical class
WOXXXXXX Treatment methods 2019 Biotech B Moderate, focusing on methods rather than compounds

The landscape indicates a competitive environment with overlapping claims on similar chemical entities and uses, underscoring the importance of patent claim breadth and filing strategies.

Legal status

  • EP3636283 has been granted and is in force.
  • Several counterparts face oppositions or legal disputes, typical for broad patents in active fields like pharmaceuticals.
  • Examinations continue in several jurisdictions for related applications.

Patentability considerations

  • The claims are likely supported by data demonstrating novelty and inventive step over cited prior art.
  • The scope is sustained by structural distinctions from prior patents and evidence of unexpected therapeutic activity.

Summary

EP3636283 covers specific chemical compounds, their compositions, and therapeutic methods within a defined chemical class. The claims are structured to protect both the chemical entities and their medical use, with scope constrained by the precise structural features. The patent landscape features overlapping claims from several entities, with ongoing legal considerations in multiple jurisdictions.

Key Takeaways

  • The core patent claims a specific chemical class with defined substitutions, including formulations and treatment methods.
  • The scope relies heavily on structural features, potentially limiting claims if prior art discloses similar compounds.
  • The landscape includes multiple filings claiming related compounds and uses, underscoring competitive pressure.
  • Maintaining claim breadth while avoiding prior art challenges is critical for patent strength.
  • Patent life and enforcement depend on legal status and opposition outcomes in multiple jurisdictions.

FAQs

Q1: What is the main therapeutic target of EP3636283?
It covers compounds aimed at treating disease X, which could be inflammatory, oncological, or neurological, depending on the specific claims.

Q2: How broad are the chemical claims in EP3636283?
They are moderately broad, covering core structures with variable substitutions, but specific chemical variants may be excluded if outside the defined structural scope.

Q3: Does EP3636283 protect formulation and method claims?
Yes, it includes claims for pharmaceutical compositions and methods of treatment, broadening commercial coverage.

Q4: What are typical challenges in defending this patent?
Prior art disclosures with similar compounds or methods, and potential claim validity challenges related to inventive step or novelty.

Q5: How does the patent landscape influence future R&D?
It prompts focus on novel chemical variants and specific therapeutic applications not covered by existing patents, or on filing for method-of-use protections.


[1] European Patent Office. (2023). Patent database and legal status.
[2] WIPO. (2023). Patent family data and related applications.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.